CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
-8.73%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.56B
AUM Growth
+$2.56B
Cap. Flow
-$400M
Cap. Flow %
-15.58%
Top 10 Hldgs %
43.81%
Holding
134
New
13
Increased
7
Reduced
67
Closed
28

Top Buys

1
GLUE icon
Monte Rosa Therapeutics
GLUE
$69.6M
2
BMEA icon
Biomea Fusion
BMEA
$48.4M
3
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$47M
4
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$44.6M
5
VERV
Verve Therapeutics
VERV
$40.6M

Top Sells

1
CCCC icon
C4 Therapeutics
CCCC
$80.8M
2
APLS icon
Apellis Pharmaceuticals
APLS
$64.2M
3
NVAX icon
Novavax
NVAX
$45.3M
4
CCXI
ChemoCentryx, Inc.
CCXI
$43.6M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$32.8M

Sector Composition

1 Healthcare 99.14%
2 Financials 0.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DCPH
76
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5.29M 0.18%
144,439
-55,561
-28% -$2.03M
AKUS
77
DELISTED
Akouos, Inc. Common Stock
AKUS
$4.95M 0.17%
394,500
-105,489
-21% -$1.32M
SRNE
78
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4.85M 0.16%
500,000
-2,250,000
-82% -$21.8M
DNTH icon
79
Dianthus Therapeutics
DNTH
$781M
$4.68M 0.16%
478,200
-121,800
-20% -$1.19M
MLTX icon
80
MoonLake Immunotherapeutics
MLTX
$3.78B
$4.45M 0.15%
430,000
– –
QTNT
81
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4.38M 0.15%
1,203,328
-296,672
-20% -$1.08M
TBPH icon
82
Theravance Biopharma
TBPH
$691M
$4.36M 0.15%
300,000
-250,000
-45% -$3.63M
DTIL icon
83
Precision BioSciences
DTIL
$59.5M
$4.34M 0.15%
346,524
– –
FVAM
84
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$3.99M 0.14%
400,000
-100,000
-20% -$997K
GTH
85
DELISTED
Genetron Holdings Limited ADS
GTH
$2.68M 0.09%
132,867
-167,133
-56% -$3.37M
AUTL
86
Autolus Therapeutics
AUTL
$383M
$2.6M 0.09%
392,167
-30,000
-7% -$199K
OBIO icon
87
Orchestra BioMed
OBIO
$147M
$2.45M 0.08%
240,000
-560,000
-70% -$5.71M
EIGR
88
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.43M 0.08%
284,988
-115,012
-29% -$980K
BCEL
89
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2.33M 0.08%
273,500
-20,000
-7% -$170K
TCDA
90
DELISTED
Tricida, Inc. Common Stock
TCDA
$1.85M 0.06%
427,975
– –
GOSS icon
91
Gossamer Bio
GOSS
$587M
$1.61M 0.05%
198,382
-650,000
-77% -$5.28M
SWTX
92
DELISTED
SpringWorks Therapeutics
SWTX
$1.24M 0.04%
15,000
-110,000
-88% -$9.06M
ORTX
93
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.13M 0.04%
256,649
– –
XFOR icon
94
X4 Pharmaceuticals
XFOR
$70M
$676K 0.02%
103,980
– –
CRDF icon
95
Cardiff Oncology
CRDF
$130M
$637K 0.02%
95,720
-54,280
-36% -$361K
NERV icon
96
Minerva Neurosciences
NERV
$16.8M
$570K 0.02%
245,744
+45,744
+23% +$106K
IMV
97
DELISTED
IMV Inc. Common Shares
IMV
$507K 0.02%
234,374
– –
CEREW
98
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$278K 0.01%
19,316
-114,015
-86% -$1.64M
NUVB.WS icon
99
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$217K 0.01%
83,332
– –
OTLKW
100
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$130K ﹤0.01%
416,666
– –
2 3
4
5 6